The use of mechanistic evidence in drug approval

The role of mechanistic evidence tends to be under‐appreciated in current evidence‐based medicine (EBM), which focusses on clinical studies, tending to restrict attention to randomized controlled studies (RCTs) when they are available. The EBM+ programme seeks to redress this imbalance, by suggestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Aronson, Jeffrey K., La Caze, Adam, Kelly, Michael P., Parkkinen, Veli‐Pekka, Williamson, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Special issue: 2018 Philosophy Thematic Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175306/
https://www.ncbi.nlm.nih.gov/pubmed/29888417
http://dx.doi.org/10.1111/jep.12960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175306/
https://www.ncbi.nlm.nih.gov/pubmed/29888417
http://dx.doi.org/10.1111/jep.12960

Ejemplares similares